BMY
Bristol-Myers Squibb Company
61.50$
+0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.89 | 1.25 | 1.82 | 3.19 | 4.32 | 4.71 | 6.22 | 7.22 | 6.09 | 6.67 | 7.49 | 6.94 | |
| 0.28 | 0.22 | 0.23 | 0.48 | 0.39 | 1.02 | 4.60 | 4.76 | 4.79 | 4.70 | 4.74 | 1.97 | |
| 0.13 | 0.14 | 0.12 | 0.12 | 0.14 | 0.26 | 0.34 | 0.26 | 0.21 | 0.25 | 0.25 | 0.27 | |
| -0.31 | 0.36 | 0.04 | 0.99 | 0.55 | -0.04 | -0.09 | -0.33 | -0.50 | – | – | – | |
| 0.14 | -0.44 | -0.69 | 1.30 | 0.13 | 1.79 | 0.44 | -0.56 | -1.04 | -0.92 | 0.40 | -0.22 | |
| 0.31 | 0.49 | 0.72 | 0.64 | 0.58 | 0.49 | 0.33 | 0.43 | 0.52 | 0.58 | 0.62 | 0.64 | |
| 0.73 | -0.94 | 0.88 | -0.04 | -1.22 | -5.71 | -4.81 | -0.24 | -0.49 | -1.10 | -10.53 | -2.02 | |
| 1.44 | 1.48 | 1.52 | 1.56 | 1.60 | 1.56 | 1.80 | 1.96 | 2.16 | 2.28 | 2.40 | 2.47 | |
| 0.15 | 0.49 | -0.14 | -1.49 | -0.20 | -4.26 | -0.68 | -2.80 | -3.73 | -2.48 | 0.00 | 0.00 | |
| -0.20 | -0.68 | 0.07 | 0.60 | -0.33 | 10.31 | 1.74 | -2.75 | -2.47 | 0.22 | 4.98 | -2.54 | |
| -1.46 | -2.16 | -1.58 | -2.47 | -2.16 | 4.45 | -0.51 | -7.23 | -7.90 | -4.53 | 2.53 | -5.07 | |
| 1.19 | -1.90 | 1.10 | 0.72 | 0.91 | 3.45 | 0.95 | -0.29 | -2.33 | 1.06 | -0.58 | -0.07 | |
| 1.57 | 0.77 | 1.10 | 2.55 | 3.74 | 4.22 | 5.89 | 6.79 | 5.57 | 6.09 | 6.88 | 6.29 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.